HUMA - Humacyte - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HUMA is currently covered by 6 analysts with an average price target of $8.6. This is a potential upside of $6.98 (430.86%) from yesterday's end of day stock price of $1.62.

Humacyte's activity chart (see below) currently has 49 price targets and 73 ratings on display. The stock rating distribution of HUMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.47% with an average time for these price targets to be met of 121.11 days.

Highest price target for HUMA is $6, Lowest price target is $3, average price target is $4.17.

Most recent stock forecast was given by RYAN ZIMMERMAN from BTIG on 12-Oct-2025. First documented stock forecast 19-Jul-2021.

Currently out of the existing stock ratings of HUMA, 31 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$6

$4.29 (250.88%)

$8

18 days ago
(12-Oct-2025)

1/8 (12.5%)

$4.24 (240.91%)

430

Buy

1 months 1 days ago
(29-Sep-2025)

0/3 (0%)

$19.58 (361.25%)

Buy

$3.5

$1.79 (104.68%)

$5

2 months 19 days ago
(11-Aug-2025)

2/8 (25%)

$1.7 (94.44%)

270

Buy

$3

$1.29 (75.44%)

$4

2 months 19 days ago
(11-Aug-2025)

0/2 (0%)

$1.2 (66.67%)

Buy

5 months 17 days ago
(13-May-2025)

0/12 (0%)

$12.35 (265.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HUMA (Humacyte) average time for price targets to be met?

On average it took 121.11 days on average for the stock forecasts to be realized with a an average price target met ratio 21.47

Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on HUMA (Humacyte)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on HUMA

Which analyst is the currently most bullish on HUMA (Humacyte)?

Suraj Kalia with highest potential upside - $14.29

Which analyst is the currently most reserved on HUMA (Humacyte)?

Bruce Jackson with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?